Skip to main content
Premium Trial:

Request an Annual Quote

Select Bio, GenNext to Co-Develop Genomic, Proteomic Seminars

NEW YORK (GenomeWeb News) — GenNext Technologies and Select Biosciences plan to co-produce meetings and educational programs that combine their experience in microarrays, proteomics, translational medicine, clinical genomics, and bioinformatics, among other disciplines, the firms said last Friday.
Select Bio said that by combining their knowledge the companies plan to offer professional development classes that will help researchers “enhance their careers.”
GenNext said the courses will blend “theory” with “how-to information.”
Select Bio has run meetings and courses covering topics such as molecular diagnostics, drug/target screening, microarrays, RNAi biomarkers, and proteomics.
GenNext, meantime, has created educational programs on translational medicine, clinical genomics, proteomics, and bioinformatics research.   

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.